Inventor · disambiguated record
Gerhard Frey
Also filed as: FREY GERHARD · FREY GERHARD JOHANN
83 granted patents·46 pending applications·1,812 citations·filing 1999–2025
99Inventor score
Top patents by PatentIndex Score
129 records- 0199US9683048B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2015·Granted Jun 20, 2017·115 cites·144 claims
- 0298US10711060B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·29 cites·5 claims
- 0398US9815898B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 14, 2017·35 cites·30 claims
- 0498US6773900B2End selection in directed evolutionDIVERSA CORP·Filed 2003·Granted Aug 10, 2004·147 cites·11 claims
- 0598US6358709B1End selection in directed evolutionDIVERSA CORP·Filed 2000·Granted Mar 19, 2002·152 cites·36 claims
- 0697US10851165B2Antibody molecules to PD-L1 and methods of treating cancerNOVARTIS AG·Filed 2018·Granted Dec 1, 2020·10 cites·80 claims
- 0797US10259873B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·21 cites·4 claims
- 0897US9988452B2Antibody molecules to PD-L1 and uses thereofNOVARTIS AG·Filed 2015·Granted Jun 5, 2018·30 cites·27 claims
- 0997US9518117B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2015·Granted Dec 13, 2016·23 cites·6 claims
- 1097US9518116B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2015·Granted Dec 13, 2016·27 cites·9 claims
- 1197US9221908B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2013·Granted Dec 29, 2015·46 cites·5 claims
- 1297US8709755B2Mirac proteinsSHORT JAY M·Filed 2012·Granted Apr 29, 2014·38 cites·3 claims
- 1397US6740506B2End selection in directed evolutionDIVERSA CORP·Filed 2001·Granted May 25, 2004·84 cites·4 claims
- 1497US6713282B2End selection in directed evolutionDIVERSA CORP·Filed 2002·Granted Mar 30, 2004·83 cites·29 claims
- 1597US6361974B1Exonuclease-mediated nucleic acid reassembly in directed evolutionDIVERSA CORP·Filed 2000·Granted Mar 26, 2002·288 cites·15 claims
- 1697US6238884B1End selection in directed evolutionDIVERSA CORP·Filed 1999·Granted May 29, 2001·238 cites·21 claims
- 1796US11773509B2Conditionally active polypeptides and methods of generating themBIOATLA INC·Filed 2021·Granted Oct 3, 2023·2 cites·19 claims
- 1896US10752687B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2017·Granted Aug 25, 2020·6 cites·90 claims
- 1996US9908936B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Mar 6, 2018·23 cites·30 claims
- 2096US8062866B2Humanized anti-IL-6 antibodiesFREY GERHARD·Filed 2009·Granted Nov 22, 2011·49 cites·24 claims
- 2195US11897959B2Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereofBIOATLA INC·Filed 2021·Granted Feb 13, 2024·2 cites·20 claims
- 2295US11111288B2Conditionally active chimeric antigen receptors for modified t-cellsBIOATLA LLC·Filed 2018·Granted Sep 7, 2021·9 cites·23 claims
- 2395US7407677B2Enzymes having alpha amylase activity and methods of use thereofVERENIUM CORP·Filed 2002·Granted Aug 5, 2008·32 cites·36 claims
- 2494US11827704B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2020·Granted Nov 28, 2023·2 cites·43 claims
- 2594US10822426B2Humanized anti-CD73 antibodiesCORVUS PHARMACEUTICALS INC·Filed 2016·Granted Nov 3, 2020·11 cites·27 claims
- 2694US8338131B2Amylases and methods for use in starch processingCALLEN WALTER·Filed 2010·Granted Dec 25, 2012·16 cites·21 claims
- 2794US7273740B2Enzymes having alpha amylase activity and methods of use thereofVERENIUM CORP·Filed 2002·Granted Sep 25, 2007·24 cites·38 claims
- 2894US6673552B2Methods for purifying annealed double-stranded oligonucleotides lacking base pair mismatches or nucleotide gapsDIVERSA CORP·Filed 2002·Granted Jan 6, 2004·79 cites·34 claims
- 2993US12110611B2Conditionally active biological proteinsBIOATLA INC·Filed 2022·Granted Oct 8, 2024·1 cites·8 claims
- 3093US11851499B2Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2020·Granted Dec 26, 2023·2 cites·27 claims
- 3191US11472876B2Conditionally active polypeptidesBIOATLA INC·Filed 2016·Granted Oct 18, 2022·4 cites·11 claims
- 3291US11279924B2Conditionally active polypeptides and methods of generating themBIOATLA LLC·Filed 2017·Granted Mar 22, 2022·3 cites·21 claims
- 3391US11254932B2Conditionally active biological proteinsBIOATLA LLC·Filed 2020·Granted Feb 22, 2022·2 cites·32 claims
- 3490US10669336B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 2, 2020·4 cites·2 claims
- 3590US7666633B2Enzymes having alpha amylase activity and methods of making and using themVERENIUM CORP·Filed 2006·Granted Feb 23, 2010·7 cites·24 claims
- 3690US2025066479A1Antibody molecules to pd-1 and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 3789US11149088B2Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereofBIOATLA LLC·Filed 2017·Granted Oct 19, 2021·3 cites·6 claims
- 3889US6939689B2Exonuclease-mediated nucleic acid reassembly in directed evolutionDIVERSA CORP·Filed 2001·Granted Sep 6, 2005·34 cites·11 claims
- 3989US2023332135A1Mirac proteinsBIOATLA INC·Filed 2023·Application pending·0 cites
- 4088US8465741B2Antibodies and methods for making and using themFREY GERHARD·Filed 2007·Granted Jun 18, 2013·11 cites·8 claims
- 4188US2024417886A1Conditionally active biological proteinsBIOATLA INC·Filed 2024·Application pending·0 cites
- 4287US12311032B2Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2023·Granted May 27, 2025·0 cites·24 claims
- 4387US9856323B2Anti-CD22 antibodiesBIOATLA LLC·Filed 2013·Granted Jan 2, 2018·10 cites·22 claims
- 4487US9062295B2Recombinant polypeptidesVERENIUM CORP·Filed 2012·Granted Jun 23, 2015·3 cites·12 claims
- 4587US7560126B2Amylases, nucleic acids encoding them and methods for making and using themVERENIUM CORP·Filed 2003·Granted Jul 14, 2009·15 cites·49 claims
- 4687US7323336B2Enzymes having alpha amylase activity and methods of use thereofVERENIUM CORP·Filed 2002·Granted Jan 29, 2008·17 cites·27 claims
- 4787US2018334660A1Enzymes Having Alpha Amylase Activity and Methods of Making and Using ThemBASF ENZYMES LLC·Filed 2018·Application pending·0 cites
- 4886US11413340B2Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapyNOVARTIS AG·Filed 2016·Granted Aug 16, 2022·2 cites·32 claims
- 4986US9637734B2Mirac proteinsBIOATLA LLC·Filed 2014·Granted May 2, 2017·5 cites·30 claims
- 5086US2024343808A1Antibody molecules to pg-l1 and methods of treating cancer and infectious diseasesNOVARTIS AG·Filed 2023·Application pending·0 cites
Showing the top 50 of 129 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →